Evidence map›Paper›PMID 31683985›Full record

ArticleGenes2019

The

Adalgeir Arason, Bjarni A Agnarsson, Gudrun Johannesdottir, Oskar Th Johannsson, Bylgja Hilmarsdottir, Inga Reynisdottir, Rosa B Barkardottir

Open access · goldAbstract read
In one paragraph

Article in Genes, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. Biallelic GermlineInternational journal of molecular sciences · 2024
    Article
  3. Article
  4. Review
  5. Brca1Cancer science · 2022
    Article
  6. Observational
  7. Article
  8. Article
  9. Impact of Gene-Environment Interactions on Cancer Development.International journal of environmental research and public health · 2020
    Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Adalgeir ArasonDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. adalgeir@landspitali.is.
Bjarni A AgnarssonDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. bjarniaa@landspitali.is.
Gudrun JohannesdottirDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. gudrunj@landspitali.is.
Oskar Th JohannssonBMC (Biomedical Center), Faculty of Medicine, University of Iceland, 101 Reykjavik, Iceland. oskarjoh@landspitali.is.
Bylgja HilmarsdottirDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. bylgjahi@landspitali.is.
Inga ReynisdottirDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. ingar@landspitali.is.
Rosa B BarkardottirDepartment of Pathology, Landspitali - The National University Hospital of Iceland, 101 Reykjavik, Iceland. rosa@landspitali.is.
National University Hospital of Iceland · ISUniversity of Iceland · IS

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mutations in

Indexed as

HomozygotePoint MutationAdultAgedBRCA1 ProteinExonsFemaleHereditary Breast and Ovarian Cancer SyndromeHeterozygoteHumansIcelandLoss of HeterozygosityMiddle AgedPedigreeBRCA1 ProteinBRCA1 protein, humanBRCA1breast cancercancer riskhomozygous lethalityKnudson's two-hit modelLOHovarian cancertumorigenesisVUS

Identifiers

PMID31683985
PMCPMC6896150
OpenAlexW2987768613

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.